SCHEDULE: Janus Henderson Group Increases Stake in Surgery Partners to 10.1%

Janus Henderson Group plc and its affiliate, Janus Henderson Contrarian Fund, have reported an increased beneficial ownership in Surgery Partners, Inc., holding an aggregate of 12,954,916 shares, representing 10.1% of the common stock as of June 30, 2025.

Summary

• Janus Henderson Group plc, a Jersey-based parent holding company and investment adviser, reported beneficial ownership of 12,954,916 shares of Surgery Partners, Inc. common stock.
• This aggregate amount represents 10.1% of the outstanding common stock of Surgery Partners, Inc.
• Janus Henderson Contrarian Fund, a Massachusetts-based investment company and an indirect subsidiary of Janus Henderson Group plc, reported beneficial ownership of 11,678,754 shares, which constitutes 9.1% of the class.
• Both Janus Henderson Group plc and Janus Henderson Contrarian Fund hold shared voting and shared dispositive power over their respective reported shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Surgery Partners, Inc.

Sentiment

Score: 5

Explanation: The document is a factual report of beneficial ownership, which inherently carries a neutral sentiment. It does not contain performance data or forward-looking statements that would typically influence sentiment.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Increased institutional ownership by Janus Henderson Group plc and its affiliate may be viewed positively by some investors as a sign of confidence in Surgery Partners, Inc.

Key Dates

Keywords

Surgery Partners Inc, Janus Henderson Group plc, Janus Henderson Contrarian Fund, SEC filing, Schedule 13G, beneficial ownership, common stock, institutional ownership, investment adviser, healthcare services